Medpace Holdings, Inc.
MEDP Healthcare Diagnostics & Research
Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.
- Revenue
- +8.50%
- EPS
- +24.6%
- Free cash flow
- −16.6%
Quarter to September 2026, against a year earlier
Follow MEDP
Alert me
Medpace Holdings, Inc. (MEDP) Book value per share
Medpace Holdings, Inc.'s book value per share at the end of fiscal 2025 was 15.9×, down 40.3% from 26.7× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 20.9×. Over the past ten years it has ranged from 11.9× (fiscal 2022) to 26.7× (fiscal 2024); the current reading is higher than 36% of that period. Medpace Holdings, Inc. ranks 13th of 49 Diagnostics & Research companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 15.9× | (40.32%) |
| FY2024 | 26.7× | 46.57% |
| FY2023 | 18.2× | 52.51% |
| FY2022 | 11.9× | (55.10%) |
| FY2021 | 26.6× | 17.51% |
| FY2020 | 22.6× | 11.71% |
| FY2019 | 20.2× | 22.01% |
| FY2018 | 16.6× | 28.67% |
| FY2017 | 12.9× | (24.66%) |
| FY2016 | 17.1× | 29.72% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 20.9× | 35.95% |
| Jun 2026 | 15.4× | (26.79%) |
| Mar 2026 | 21.0× | 32.17% |
| Dec 2025 | 15.9× | 52.49% |
| 40 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| ICLR ICON PLC compare | 119× |
| LH Labcorp Holdings Inc. compare | 109× |
| DGX Quest Diagnostics Incorporated compare | 72.3× |
| CRL Charles River Laboratories International, Inc. compare | 67.6× |
| MEDP Medpace Holdings, Inc. | 20.9× |
| ILMN Illumina, Inc. compare | 20.8× |
| QGEN QIAGEN N.V. compare | 16.3× |
| RVTY Revvity Inc. compare | 0.0× |
| GH Guardant Health, Inc. compare | −2.1× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on MEDP
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement